Author: Andrew
US-Australian drug discovery and development company, Novogen Limited (ASX:NRT; NASDAQ:NVGN), announced today the non-renounceable pro-rata rights issue entitlement announced on 21 April 2015 (Rights Issue) was completed successfully.
Six exhibitions for nano, micro/MEMS, laser, advanced ceramics, 3D printing and bionics technologies
MT7623 and MT7683 feature innovative TRGMII (“Turbo” ethernet interface) to allow bi-directional traffic between WLAN and LAN for a faster connected experience
Industry’s first One-2-One visual security solution to easily and readily identify legitimacy of card holder
Wirecard Group, with its New Zealand subsidiary GFG Group Limited, today announced that Cuscal Limited, one of Australia’s leading payment services companies, has selected Wirecard as solution partner for its next generation acquiring and issuing processing business.
Triggers a new era of dating and marriage services; completes re-funding of US$246 million; plans for public listing
Alliance to provide 200 pure electric vehicles to 2015 Paris climate conference The first fully electric shuttle service for United Nation’s climate conference Fleet to include Renault ZOE and Kangoo Z.E, Nissan LEAF and e-NV200 More than 50 charging stations powered by renewable energy to be established in and around Paris.
Anil K. Gupta: “Global problems require Global Collaborative Solutions.”The Global Cleantech Summit 2015 to be organized in Helsinki in September provides an international discussion and innovation forum for the global challenges of today: How to mitigate the impacts of climate change and the other pressing environmental concerns? How to succeed and take effective steps towards a better future with clean technologies?
ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for Tentative Approval, to the Food and Drug Administration (FDA), for the treatment of HIV. This is the first ANDA for a generic version of dolutegravir, less than two years after FDA approval of TivicayŽ (dolutegravir) for sale in the United States.
Nearly three million people, in four of the biggest cities in Kazakhstan – Almaty, Astana, Shymkent and Oral (Uralsk) – had the chance to take part in the Olympic Day celebrations organised by the National Olympic Committee of Kazakhstan, the Ministry of Culture and Sports, the respective city administrations and the Organizing Committee for International Sports events in Almaty city to support Almaty’s bid for the Winter Olympic and Paralympic Games in 2022.